InvestorsHub Logo
Followers 0
Posts 1587
Boards Moderated 0
Alias Born 08/09/2015

Re: XenaLives post# 11903

Wednesday, 07/03/2019 5:56:56 PM

Wednesday, July 03, 2019 5:56:56 PM

Post# of 21540
The question with this drug is efficacy and the upcoming P2 will answer the question. Anyone focused on safety of this drug does not understand drug development. This drug has had more safety monitoring than any other drug at this stage of development. Safety is never proven 100% prior to marketing and is never 100% during marketing. But, given the amount of safety monitoring of this drug at this stage of development is well beyond what is normally performed. So, efficacy is the question, I would not be concerned at all about safety. Spending time on such a question is a complete waste of time and a disservice to this board.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNPX News